뒤로
INVO Fertility Inc(IVF) 가격
IVF 주가 차트
IVF 수입
INVO Fertility Inc
$1.63
-7.38%
$-0.13
종가: Jan 23, 16:00:00 GMT-5
$1.39
-14.7%
$-0.23
애프터마켓: Jan 23, 20:00:00 GMT-5
최신 수익 결과: Q3 '25
보고됨: 2025-11-17
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
IVF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
INVO Fertility Inc IVF의 지난 분기 매출 실적은 어땠나요?
INVO Fertility Inc의 매출 추정치는 얼마인가요?
INVO Fertility Inc의 수익 품질 점수는 얼마인가요?
INVO Fertility Inc는 언제 수익을 보고하나요?
INVO Fertility Inc의 예상 수익은 얼마인가요?
INVO Fertility Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$1.76
시가
$1.66
일일 범위
$1.39 - $1.84
52주 범위
$0.71 - $148.32
거래량
1.1M
평균 거래량
540.5K
EPS(TTM)
-440.26
배당수익률
--
시가총액
$2.6M
IVF란 무엇인가요?
INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services company focused on the fertility marketplace and expanding access to assisted reproductive technology (ART) care for patients in need. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.